New

South America Virology Market

2021

South America Virology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Test, Viral Infection Controlling Techniques, Antiviral Therapeutics, and Interferons), Application (Skin and Soft Tissue Infections, Respiratory Tract Infections, GI Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Pharmaceutical and Biotechnological Companies, and Research and Academic Institutes)

Publication Month: Nov 2021 | Report Code: TIPRE00025740 | No. of Pages: 177 | Category: Biotechnology | Status: Published

Market Insights

South America Virology Market to Grow at a CAGR of 3.1% to reach US$ 314.27 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The virology market in SAM is expected to grow from US$ 254.48 million in 2021 to US$ 314.27 million by 2028; it is estimated to grow at a CAGR of 3.1% from 2021 to 2028.

Brazil and Argentina are economies in South America. Viral infection is among the leading causes of human chronic diseases. A few viruses, such as human immunodeficiency virus (HIV), flu virus, Zika, Diphtheria, Ebola, SARS-CoV-2 (COVID-19), Polio, and Tetanus (Lockjaw), infect large populations across the world. As virus mutate and evolve continuously, drug resistance become an impending challenge for viral infection management among the human and animals. A virus transmits through various mediums based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, transmits through droplets generated through coughing or sneezing, while some because gastrointestinal viral diseases transmitted through feces contaminated food or water. The novel coronavirus that causes COVID-19 was identified in 2019. The International Committee on Taxonomy of Viruses (ICTV) declared the virus as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) on February 11, 2020, and later WHO named the disease as COVID-19. The virus has undergone mutation a couple of times since its outbreak, which has added to the severity of the COVID-19 pandemic. Therefore, the rising prevalence of viral infections drives the growth of the SAM virology market.

COVID-19 has created shock waves with severe health, economic and social consequences, which will affect many countries in South America in the future. The COVID-19 pandemic has brought the risk of major disease outbreaks and highlighted countries’ lack of preparedness to fight them. Climate change, urbanization, and the lack of water and sanitation are contributing to fast-spreading outbreaks. Argentina was already in a fragile socio-economic situation before the COVID-19. According to the National Institute of Statistics and Censuses (INDEC), economic activity fell by 10.3% in May 2020, while annual inflation reached 42.8% in June 2020. The fragile health systems in many of these countries and their limited means to finance or drive vaccine development on their own have also put the large population at heightened risk. The COVID-19 pandemic has disrupted healthcare services across South America. For instance, in Guatemala, the COVID-19 has severely impacted HIV services; HIV testing decreased by 54.7% in 2020. As per the PAHO, since the onset of the pandemic, the number of people being tested for HIV in Latin America has dropped sharply. COVID-19 is expected to exacerbate this situation, especially in countries with fragile health systems.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive virology market. The SAM virology market is expected to grow at a good CAGR during the forecast period.
SAM virology market

Get more information on this report :


SAM Virology Market Segmentation

SAM Virology Market – By Type

  • Diagnostic Test
    • DNA Virus Testing
    • RNA Virus Testing
    • Others
  • Viral Infection Controlling Techniques
    • Active Prophylaxis
    • Passive Prophylaxis
  • Antiviral Therapeutics
    • Virucidal Agents
    • Antiviral Agents
    • Immunomodulators
  • Interferons

SAM Virology Market – By Application

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Others

SAM Virology Market – By End User

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnological Companies
  • Research and Academic Institutes

SAM Virology Market- By Country

  • Brazil
  • Argentina
  • Rest of SAM

SAM Virology Market-Companies Mentioned

  • Abbott
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline Plc
  • Illumina, Inc.
  • Johnson and Johnson Services, Inc.
  • QIAGEN
  • Siemens AG
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Virology Market – By Type

1.3.2 SAM Virology Market – By Application

1.3.3 SAM Virology Market – By End User

1.3.4 SAM Virology Market– By Country

2. SAM Virology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Virology Market– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. SAM Virology Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Viral Infectious Diseases

5.1.2 Surging Product Launches

5.2 Market Restraints

5.2.1 Availability of Alternative Products and High Cost of Production of Products

5.3 Market Opportunities

5.3.1 Immense Growth Potential in Emerging Economies

5.4 Future Trends

5.4.1 Continuous Demand for Cost-Effective Products

5.5 Impact Analysis

6. Virology Market– SAM Analysis

6.1 SAM Virology Market Revenue Forecast and Analysis

7. SAM Virology Market Analysis – By Type

7.1 Overview

7.2 SAM Virology Market Revenue Share, by Type (2021 and 2028)

7.3 Diagnostic Test

7.3.1 Overview

7.3.2 Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Deoxyribonucleic Acid (DNA) Virus Testing

7.3.2.1.1 Overview

7.3.2.1.2 DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Ribonucleic Acid (RNA) Virus Testing

7.3.2.2.1 Overview

7.3.2.2.2 RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Others

7.3.2.3.1 Overview

7.3.2.3.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Viral Infection Controlling Techniques

7.4.1 Overview

7.4.2 Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.1 Active Prophylaxis

7.4.2.1.1 Overview

7.4.2.1.2 Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.4.2.2 Passive Prophylaxis

7.4.2.2.1 Overview

7.4.2.2.2 Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Antiviral Therapeutics

7.5.1 Overview

7.5.2 Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.1 Virucidal Agents

7.5.2.1.1 Overview

7.5.2.1.2 Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.2 Antiviral Agents

7.5.2.2.1 Overview

7.5.2.2.2 Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.5.2.3 Immunomodulators

7.5.2.3.1 Overview

7.5.2.3.2 Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Interferons

7.6.1 Overview

7.6.2 Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8. SAM Virology Market Analysis – By Application

8.1 Overview

8.2 SAM Virology Market, by Application 2021 & 2028 (%)

8.3 Skin and Soft Tissue Infections

8.3.1 Overview

8.3.2 Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Respiratory Tract Infections

8.4.1 Overview

8.4.2 Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.5 GI Tract Infections

8.5.1 Overview

8.5.2 GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Sexually Transmitted Diseases

8.6.1 Overview

8.6.2 Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Urinary Tract Infections

8.7.1 Overview

8.7.2 Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9. SAM Virology Market Analysis – By End User

9.1 Overview

9.2 SAM Virology Market Revenue Share, by End User (2021 and 2028)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Diagnostic Laboratories

9.4.1 Overview

9.4.2 Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Pharmaceutical and Biotechnological Companies

9.5.1 Overview

9.5.2 Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

9.6 Research and Academic Institutes

9.6.1 Overview

9.6.2 Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

10. SAM Virology Market – Country Analysis

10.1.1 Overview

10.1.2 South America: Virology Market, by Country, 2021 & 2028 (%)

10.1.2.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1 Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2 Brazil: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.1.2.1 Brazil: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.1.2.2 Brazil: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.1.2.3 Brazil: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.1.3 Brazil: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.1.4 Brazil: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.2 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1 Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2 Argentina: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.2.2.1 Argentina: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.2.2.2 Argentina: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.2.2.3 Argentina: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.2.3 Argentina: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.2.4 Argentina: Virology Market, by End User, 2019–2028 (USD Million)

10.1.2.3 Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1 Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2 Rest of South America: Virology Market, By Type, 2019–2028 (USD Million)

10.1.2.3.2.1 Rest of South America: Virology Market, by Diagnostic Test, 2019–2028 (USD Million)

10.1.2.3.2.2 Rest of South America: Virology Market, by Viral Infection Controlling Techniques, 2019–2028 (USD Million)

10.1.2.3.2.3 Rest of South America: Virology Market, by Antiviral Therapeutics, 2019–2028 (USD Million)

10.1.2.3.3 Rest of South America: Virology Market, by Application, 2019–2028 (USD Million)

10.1.2.3.4 Rest of South America: Virology Market, by End User, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on SAM Virology Market

11.1 Overview

12. SAM Virology Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Johnson and Johnson Services, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 F. HOFFMANN-LA ROCHE LTD.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 THERMO FISHER SCIENTIFIC INC.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 QIAGEN

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Illumina, Inc.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Siemens AG

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 GlaxoSmithKline Plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 AbbVie Inc.

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Gilead Sciences, Inc.

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. SAM Virology Market Revenue and Forecast to 2028 (US$ Million)

Table 2. Brazil: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3. Brazil Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 4. Brazil Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 5. Brazil Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 6. Brazil: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7. Brazil: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 8. Argentina: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 9. Argentina Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 10. Argentina Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million)

Table 11. Argentina Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 12. Argentina: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. Argentina: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14. Rest of South America: Virology Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15. Rest of South America Virology Market, by Diagnostic Test– Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of South America Virology Market, by Viral Infection Controlling Techniques– Revenue and Forecast to 2028 (USD Million

Table 17. Rest of South America Virology Market, by Antiviral Therapeutics– Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of South America: Virology Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Rest of South America: Virology Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, SAM Virology Market

LIST OF FIGURES

Figure 1. SAM Virology Market Segmentation

Figure 2. SAM Virology Segmentation, By Country

Figure 3. SAM Virology Market Overview

Figure 4. Antiviral Therapeutics Held the Largest Share of the Type Segment in SAM Virology Market

Figure 5. Respiratory Tract Infections Held the Largest Share of the Application Segment in SAM Virology Market

Figure 6. Brazil to Show Significant Growth During Forecast Period

Figure 7. SAM PEST Analysis

Figure 8. SAM Virology Market: Impact Analysis of Drivers and Restraints

Figure 9. SAM Virology Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10. SAM Virology Market Revenue Share, by Type (2021 and 2028)

Figure 11. SAM Diagnostic Test: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. SAM DNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. SAM RNA Virus Testing: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. SAM Viral Infection Controlling Techniques: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. SAM Active Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. SAM Passive Prophylaxis: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. SAM Antiviral Therapeutics: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. SAM Virucidal Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. SAM Antiviral Agents: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. SAM Immunomodulators: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22. SAM Interferons: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23. SAM Virology Market, by Application 2021 & 2028 (%)

Figure 24. SAM Skin and Soft Tissue Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25. SAM Respiratory Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26. SAM GI Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27. SAM Sexually Transmitted Diseases: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28. SAM Urinary Tract Infections: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. SAM Others: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. SAM Virology Market Revenue Share, by End User (2021 and 2028)

Figure 31. SAM Hospitals: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. SAM Diagnostic Laboratories: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. SAM Pharmaceutical and Biotechnological Companies: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. SAM Research and Academic Institutes: Virology Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. South America: Virology Market, by Key Country – Revenue (2021) (USD Million)

Figure 36. South America: Virology Market, by Country, 2021 & 2028 (%)

Figure 37. Brazil: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 38. Argentina: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Rest of South America: Virology Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Impact of COVID-19 Pandemic on Virology Market in SAM Countries

  1. Abbott
  2. AbbVie Inc.
  3. F. Hoffmann-La Roche Ltd.
  4. Gilead Sciences, Inc.
  5. GlaxoSmithKline Plc
  6. Illumina, Inc.
  7. Johnson and Johnson Services, Inc.
  8. QIAGEN
  9. Siemens AG
  10. Thermo Fisher Scientific Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM Virology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM Virology market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the Virology market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
TIPRE00025740
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.